A detailed history of Sterling Capital Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Sterling Capital Management LLC holds 56,846 shares of BMY stock, worth $3.29 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
56,846
Previous 1,323,691 95.71%
Holding current value
$3.29 Million
Previous $67.1 Million 4281.76%
% of portfolio
0.04%
Previous 0.64%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$39.66 - $51.75 $50.2 Million - $65.6 Million
-1,266,845 Reduced 95.71%
56,846 $2.94 Billion
Q3 2019

Nov 14, 2019

BUY
$42.77 - $50.71 $56.6 Million - $67.1 Million
1,323,691 New
1,323,691 $67.1 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Sterling Capital Management LLC Portfolio

Follow Sterling Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sterling Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sterling Capital Management LLC with notifications on news.